Aster Susan D, Graham Donald W, Kharbanda Divya, Patel Gool, Ponpipom Mitree, Santorelli Gina M, Szymonifka Michael J, Mundt Steven S, Shah Kashmira, Springer Marty S, Thieringer Rolf, Hermanowski-Vosatka Anne, Wright Samuel D, Xiao Jianying, Zokian Hratch, Balkovec James M
Department of Medicinal Chemistry, Merck & Co., Inc., PO Box 2000, Rahway, NJ 07065, USA.
Bioorg Med Chem Lett. 2008 May 1;18(9):2799-804. doi: 10.1016/j.bmcl.2008.04.010. Epub 2008 Apr 9.
3-Aryl-5-phenyl-(1,2,4)-triazoles were identified as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1). They are active in both in vitro and an in vivo mouse pharmacodynamic (PD) model. The synthesis and structure activity relationships are presented.
3-芳基-5-苯基-(1,2,4)-三唑被鉴定为11β-羟基类固醇脱氢酶1型(11β-HSD1)的选择性抑制剂。它们在体外和体内小鼠药效学(PD)模型中均具有活性。本文介绍了其合成方法及构效关系。